A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2004.36.5.287
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2004
Authors
Publisher
Korean Cancer Association